Back to results
US 6,150,411 AGranted
Use of DHA as a pharmaceutical composition
OwnerBarbara Jacqueline Stordyinventor
Life of this patent
Estimating the term…
Abstract
Dyslexia or inadequate night vision is treated by administering effective amounts of docosohexaenoic acid optionally in association wit other n-3 essential fatty acids and n-6 essential fatty acids.
Claims12
A method of treating dyslexia comprising administering to a subject in need of same docosahexaenoic (DHA) in an effective amount.
Dependencies are inferred from the claim text.